MACROCYCLIC COMPOUNDS AND USES THEREOF

The invention relates to selected macrocyclic compounds, and their use in the treatment or prevention of diseases and disorders. In particular, though not exclusively, the invention relates to the use of selected macrocyclic compounds in the treatment or prevention of diseases that are caused by (1) cell death due to various causes and (2) inflammation. Such diseases can affect all parts of the body, including the central and peripheral nervous systems, all organs and tissues, the muscles, the vasculature and the bones..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 23. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

STEADMAN VICTORIA ALEXANDRA [VerfasserIn]
DEAN DAVID KENNETH [VerfasserIn]
STANWAY STEVEN [VerfasserIn]
WILSON ANTOINETTE [VerfasserIn]
KEATS ANDREW [VerfasserIn]
PEEL MICHAEL [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-23, Last update posted on www.tib.eu: 2024-01-19, Last updated: 2024-01-26

Patentnummer:

WO2023223057

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018728928